Collaborateur senior
Bella regularly advises companies ranging from early stage start-ups to late stage unicorns on a wide range of corporate matters. Bella started her career as a venture capital lawyer in San Francisco before moving to London. Her clients value her commercial insight into trends and norms in the Californian start-up market. Bella's practice is focused on technology start-ups with particular emphasis on consumer goods, SaaS, healthcare, and fintech.
We have advised Blue Earth Therapeutics and its management on the closing of US$76.5 million Series A funding. The new funding comes from a broad spectrum of experienced biotech investors and enables Blue Earth Therapeutics to further advance its clinical stage prostate-specific membrane antigen-targeted radioligand therapies.
Press releaseWe have advised AlveoGene, a new UK gene therapy company on its complex spinout from the Gene Therapy Consortium of Imperial College and the Universities of Oxford and Edinburgh focusing on rare respiratory diseases, as well as on its seed round investment.
Press release
par plusieurs auteurs
Blue Earth Therapeutics raises US$76.5 million Series A funding
Leading data and analytics provider BMLL secures $21 million strategic investment
par plusieurs auteurs
par plusieurs auteurs
par plusieurs auteurs
par plusieurs auteurs
par plusieurs auteurs
par Mareike Christine Gehrmann et Carla Nelles, LL.M. (Amsterdam)
par plusieurs auteurs
par Katie Chandler et Esha Marwaha
par Graham Hann et Kelly Burke
par plusieurs auteurs